| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
77,400,000 |
| Market
Cap: |
687.31(M) |
| Last
Volume: |
924,004 |
Avg
Vol: |
1,535,793 |
| 52
Week Range: |
$4.32 - $9.91 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security markets. Co.'s primary product, TPOXX®, is a U.S. Food & Drug Administration-approved oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Odden John |
VP - Business Development |
• – – |
2004-12-28 |
4 |
B |
$1.53 |
$612 |
D/D |
400 |
30,240 |
2.66 |
- |
|
| Antal James |
Director |
– • – |
2004-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,154 |
|
- |
|
| Odden John |
VP - Business Development |
• – – |
2004-10-12 |
4 |
B |
$1.51 |
$45,292 |
D/D |
29,840 |
29,840 |
2.74 |
- |
|
| Kasten Bernard L |
Chief Executive Officer |
• • – |
2004-10-11 |
4 |
B |
$1.44 |
$77,018 |
D/D |
53,559 |
553,559 |
2.81 |
- |
|
| Burgess Susan K |
Former President+ |
– – – |
2004-06-09 |
4 |
S |
$1.50 |
$15,000 |
D/D |
(10,000) |
365,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2004-04-05 |
4 |
S |
$1.90 |
$39,536 |
D/D |
(20,800) |
375,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2004-04-02 |
4 |
S |
$1.92 |
$6,146 |
D/D |
(3,200) |
396,583 |
|
- |
|
| Macandrews & Forbes Holdings Inc |
10% Owner |
– – • |
2004-01-08 |
4 |
OE |
$1.44 |
$6,840,595 |
I/I |
4,750,413 |
3,472,222 |
|
- |
|
| Transtech Pharma Inc |
10% Owner |
– – • |
2004-01-08 |
4 |
OE |
$1.44 |
$5,000,000 |
D/D |
3,472,222 |
3,472,222 |
|
- |
|
| Savas Paul G |
Director |
– • – |
2004-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,361 |
|
- |
|
| Mjalli Adnan M M |
Director |
– • • |
2004-01-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,472,222 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-12-01 |
4 |
S |
$1.84 |
$5,520 |
D/D |
(3,000) |
399,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-11-26 |
4 |
S |
$1.80 |
$2,700 |
D/D |
(1,500) |
402,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-11-25 |
4 |
S |
$1.80 |
$15,320 |
D/D |
(8,500) |
404,283 |
|
- |
|
| Weiner Michael Md |
Director |
– • – |
2003-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
112,500 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-10-27 |
4 |
S |
$2.31 |
$29,996 |
D/D |
(13,000) |
412,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-10-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
425,783 |
|
- |
|
| Burgess Susan K |
President |
• – – |
2003-10-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,000 |
5,000 |
|
- |
|
| Macandrews & Forbes Holdings Inc |
10% Owner |
– – • |
2003-10-08 |
4 |
OE |
$1.44 |
$2,010,905 |
I/I |
1,396,462 |
2,578,374 |
|
- |
|
| Macandrews & Forbes Holdings Inc |
10% Owner |
– – • |
2003-08-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,181,912 |
|
- |
|
| Drapkin Donald G |
Director |
– • • |
2003-07-09 |
4 |
S |
$1.70 |
$848,174 |
D/D |
(498,926) |
1,798,326 |
|
- |
|
371 Records found
|
|
Page 15 of 15 |
|
|
0.07 (0.79%) 
